X4 PHARMACEUTICALS, INC
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $33.1M | $64.4M | $81.8M |
| FY2022 | $32.3M | $74.1M | $121.7M |
| FY2023 | $54.6M | $51.1M | $99.2M |
| FY2024 | $75.0M | $22.1M | $55.7M |
| FY2025 | $75.0M | $186.3M | $217.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $33.1M | $64.4M | $81.8M |
| FY2022 | $32.3M | $74.1M | $121.7M |
| FY2023 | $54.6M | $51.1M | $99.2M |
| FY2024 | $75.0M | $22.1M | $55.7M |
| FY2025 | $75.0M | $186.3M | $217.0M |